Our Team

The A-SKIN team builds on members with specific expertise. The senior scientists as well as the physicians are seasoned and offer a long standing scientific and/or clinical experience in their fields. This is reflected by multiple scientific publications in national and international journals in the fields of regenerative medicine, skin tissue engineering, allergic contact dermatitis and compound screening for irritancy and allergenicity.

The A-SKIN core team is supported by an extended network of dedicated professionals, with ample expertise for marketing of life science products, patents and licensing.

Prof. dr. R. (Rik) J. Scheper CEO, Chairman of the Board

(Co-)founder and active member of the European Research Group on Experimental Contact Dermatitis. ERGECD members have convened since the early eighties in informal meetings which gather experts in the field of skin toxicology, immunology and contact dermatitis including chemists, pharmacologists, epidemiologists, clinicians, cell biologists and immunologists. The most recent meeting took place in Paris (2014; link )and Lyon.
(Co)founder and member of the European Environmental Contact Dermatitis Research Group. Most EECDRG members are clinically active dermato-allergologists with a keen interest in diagnostic and preventive measures in allergic skin disease, as well as in consumer and occupational issues. Last meeting took place in Leuven (2016: link)

To further develop his work on human dendritic cell lines in allergy and cancer he (co-) founded DC-Prime BV aiming at novel tumor vaccines. Currently he serves DCPrime as member of the Scientific Advisory Board.

Prof.dr. S. Gibbs Director Research & Development

Prof. Dr. Gibbs studied human physiology and biochemistry in Sheffield (GB). She obtained her PhD in molecular genetics in 1991 in Leiden. In 1993 she became head of the Dermatology research laboratory in VUMC, Amsterdam. The development and application of cultured skin and oral mucosa is her major interest. Her entire career has focused on human skin biology, and in particular in animal alternative methods to develop novel therapeutic strategies for treating and preventing human skin disease. In July 2012, Prof Gibbs’ leading position in the field of skin tissue engineering was be awarded with the Fenna Diemer-Lindeboom chair as Professor of Skin and Mucosa Regenerative Medicine aimed at promoting female scientific talent. This unique position is jointly supported by the VU University Medical Centre and the Academic Centre for Dentistry Amsterdam (ACTA).


A-SKIN develops cell and skin tissue products for the treatment of difficult to heal skin wounds.
Back to top